The entire Quebecor family is deeply saddened by the passing of the Right Honourable Brian Mulroney
MONTRÉAL, Feb. 29, 2024 /CNW/ - The entire Quebecor family was grieved to learn the passing of the Right Honourable Brian Mulroney, a pillar of the Corporation's Board of Directors for more than 20 years and its Chair since 2014. The Corporation pays tribute to this great man, who leaves an enduring legacy in the political, economic and philanthropic life of Québec and Canada.
"Mr. Mulroney has left his mark not only on Canadian history, but also the history of our Corporation," said Pierre Karl Péladeau, President and CEO of Quebecor. "In the late 60s, he was a trusted advisor to my late father, Pierre Péladeau, and became an invaluable mentor to me. It was a privilege to be able to count on his vast experience and wisdom. His sound counsel played an important role in Quebecor's growth and its present-day success."
"Mr. Mulroney was an exceptional person, a man of tremendous class and unparalleled generosity," said Sylvie Lalande, Vice-Chair of the Board and Lead Director of Quebecor. "Today Quebecor has lost an esteemed colleague who brought unique leadership to the Board and left an indelible mark on the business community of Québec and Canada. We all owe him a great debt of gratitude."
"On behalf of the Board and the entire Quebecor family, I would like to extend our sincere condolences to his wife Mila, his children Caroline, Benedict, Mark and Nicolas, his grandchildren and all the members of his family," said Mr. Péladeau. "He will be sorely missed."
Elbit Systems Ltd. ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...